c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma

Alessandra Di Bacco, Nizar J. Bahlis, Nikhil C. Munshi, Hervé Avet-Loiseau, Tamás Masszi, Luísa Viterbo, Ludek Pour, Peter Ganly, Michele Cavo, Christian Langer, Shaji K. Kumar, S. Vincent Rajkumar, Jonathan J. Keats, Deborah Berg, Jianchang Lin, Bin Li, Sunita Badola, Lei Shen, Jacob Zhang, Dixie Lee EsseltineKatarina Luptakova, Helgi van de Velde, Paul G. Richardson, Philippe Moreau

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint Dive into the research topics of 'c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences